Refine
Year of publication
Document Type
- Article (62)
- Preprint (3)
- Contribution to a Periodical (1)
- Other (1)
Has Fulltext
- yes (67)
Is part of the Bibliography
- no (67)
Keywords
- ABC Transporter (4)
- ATPases (4)
- Biophysical chemistry (4)
- membrane proteins (4)
- Antigen Processing (3)
- Atomic force microscopy (3)
- MHC (3)
- Membrane proteins (3)
- antigen presentation (3)
- ABC transporter (2)
- ABC transporters (2)
- Brownian dynamics simulation (2)
- CRISPR/Cas9 (2)
- Cell biology (2)
- G protein-coupled receptors (2)
- HLA class I (2)
- Immunology (2)
- Mass spectrometry (2)
- Membrane biophysics (2)
- Molecular dynamics simulation (2)
- Single molecule force spectroscopy (2)
- Transporters (2)
- antigen processing (2)
- molecular machines (2)
- peptide-loading complex (2)
- resistance mutation (2)
- serine protease (NS3-4A) (2)
- von Willebrand factor (2)
- 3D EM (1)
- ABC proteins (1)
- ABC proteins, ribosome recycling (1)
- APM (1)
- Alveolar macrophages (1)
- Antigen processing and presentation (1)
- Antigens/Peptides/Epitopes (1)
- Bacteriophages (1)
- Biochemistry (1)
- Biological techniques (1)
- Biomaterials – proteins (1)
- CCR5 (1)
- CD4 binding site (1)
- CXCR4 (1)
- Cellular Immune Response (1)
- Chemical modification (1)
- Chemical tools (1)
- Cryoelectron microscopy (1)
- Cytological techniques (1)
- DNA nanopores (1)
- DNA nanostructures (1)
- EIGER detector (1)
- Enzyme mechanisms (1)
- Get Pathway (1)
- HIV-1 (1)
- Human (1)
- Immune evasion (1)
- Immunochemistry (1)
- Intracellular Trafficking (1)
- Isolation, separation and purification (1)
- Kinases (1)
- Liposomes (1)
- Major Histocompatibility Complex (MHC) (1)
- Membrane Protein (1)
- Membrane Proteins (1)
- Membranes (1)
- Multidrug Transporters (1)
- Multiphoton microscopy (1)
- Nanomedicine (1)
- Peptides (1)
- Primary hemostasis (1)
- Protein folding (1)
- Reconstitution of Membrane Transporters (1)
- Ribosome (1)
- Single-molecule biophysics (1)
- Soluble gp140 Env (1)
- Super-resolution microscopy (1)
- TAPL (1)
- Tail-anchored Proteins (1)
- Targeted drug delivery (1)
- Transport Drugs (1)
- Transporter (1)
- Tuberculosis (1)
- V3 loop (1)
- Viral Immunology (1)
- X-ray crystallography (1)
- X-ray detectors (1)
- adaptation (1)
- adaptive immunity (1)
- allosteric coupling (1)
- antigen processing and presentation (1)
- biosenors (1)
- conformational dynamics (1)
- cryo-EM (1)
- data-collection strategy (1)
- drug resistance (1)
- endoplasmic reticulum (1)
- evolution (1)
- hepatitis C virus (1)
- hepatitis C virus (HCV) (1)
- immune escape (1)
- interaction network (1)
- interdomain signal transmission (1)
- knockout (1)
- ligand binding (1)
- lysosome (1)
- mRNA surveillance (1)
- mRNA translation (1)
- macromolecular complexes (1)
- macromolecular crystallography (1)
- membrane organization (1)
- membrane transport (1)
- mitochondrial antiviral signaling protein (MAVS) (1)
- molecular adaptation (1)
- molecular biology (1)
- molecular dynamics (1)
- molecular motors (1)
- molecular tug-of-war (1)
- open structure (1)
- peptide editing (1)
- phase separation (1)
- phylogeny (1)
- primary active transporters (1)
- protease inhibitor (1)
- protein evolution (1)
- protein folding (1)
- quality control (1)
- receptor condensates (1)
- receptor dynamics (1)
- replicative fitness (1)
- ribosome quality control (1)
- ribosome-associated quality control (1)
- sequence alignment (1)
- silicon chips (1)
- single particle analysis (1)
- single-molecule analyses (1)
- solid-state nanopores (1)
- structural biology (1)
- structure constraints (1)
- substrate-binding site (1)
- tapasin (1)
- tropism (1)
- viral fitness (1)
- viral immune escape (1)
Institute
- Biochemie und Chemie (44)
- Biochemie, Chemie und Pharmazie (19)
- Sonderforschungsbereiche / Forschungskollegs (19)
- Center for Membrane Proteomics (CMP) (8)
- Exzellenzcluster Makromolekulare Komplexe (5)
- Medizin (3)
- Biowissenschaften (2)
- MPI für Biophysik (2)
- Zentrum für Biomolekulare Magnetische Resonanz (BMRZ) (2)
- Georg-Speyer-Haus (1)
Inhibitors against the NS3-4A protease of hepatitis C virus (HCV) have proven to be useful drugs in the treatment of HCV infection. Although variants have been identified with mutations that confer resistance to these inhibitors, the mutations do not restore replicative fitness and no secondary mutations that rescue fitness have been found. To gain insight into the molecular mechanisms underlying the lack of fitness compensation, we screened known resistance mutations in infectious HCV cell culture with different genomic backgrounds. We observed that the Q41R mutation of NS3-4A efficiently rescues the replicative fitness in cell culture for virus variants containing mutations at NS3-Asp168. To understand how the Q41R mutation rescues activity, we performed protease activity assays complemented by molecular dynamics simulations, which showed that protease-peptide interactions far outside the targeted peptide cleavage sites mediate substrate recognition by NS3-4A and support protease cleavage kinetics. These interactions shed new light on the mechanisms by which NS3-4A cleaves its substrates, viral polyproteins and a prime cellular antiviral adaptor protein, the mitochondrial antiviral signaling protein MAVS. Peptide binding is mediated by an extended hydrogen-bond network in NS3-4A that was effectively optimized for protease-MAVS binding in Asp168 variants with rescued replicative fitness from NS3-Q41R. In the protease harboring NS3-Q41R, the N-terminal cleavage products of MAVS retained high affinity to the active site, rendering the protease susceptible for potential product inhibition. Our findings reveal delicately balanced protease-peptide interactions in viral replication and immune escape that likely restrict the protease adaptive capability and narrow the virus evolutionary space.
The Q80K polymorphism in the NS3-4A protease of the hepatitis C virus is associated with treatment failure of direct-acting antiviral agents. This polymorphism is highly prevalent in genotype 1a infections and stably transmitted between hosts. Here, we investigated the underlying molecular mechanisms of evolutionarily conserved coevolving amino acids in NS3-Q80K and revealed potential implications of epistatic interactions in immune escape and variants persistence. Using purified protein, we characterized the impact of epistatic amino acid substitutions on the physicochemical properties and peptide cleavage kinetics of the NS3-Q80K protease. We found that Q80K destabilized the protease protein fold (p < 0.0001). Although NS3-Q80K showed reduced peptide substrate turnover (p < 0.0002), replicative fitness in an H77S.3 cell culture model of infection was not significantly inferior to the WT virus. Epistatic substitutions at residues 91 and 174 in NS3-Q80K stabilized the protein fold (p < 0.0001) and leveraged the WT protease stability. However, changes in protease stability inversely correlated with enzymatic activity. In infectious cell culture, these secondary substitutions were not associated with a gain of replicative fitness in NS3-Q80K variants. Using molecular dynamics, we observed that the total number of residue contacts in NS3-Q80K mutants correlated with protein folding stability. Changes in the number of contacts reflected the compensatory effect on protein folding instability by epistatic substitutions. In summary, epistatic substitutions in NS3-Q80K contribute to viral fitness by mechanisms not directly related to RNA replication. By compensating for protein-folding instability, epistatic interactions likely protect NS3-Q80K variants from immune cell recognition.
Membrane receptor clustering is fundamental to cell–cell communication; however, the physiological function of receptor clustering in cell signaling remains enigmatic. Here, we developed a dynamic platform to induce cluster formation of neuropeptide Y2 hormone receptors (Y2R) in situ by a chelator nanotool. The multivalent interaction enabled a dynamic exchange of histidine-tagged Y2R within the clusters. Fast Y2R enrichment in clustered areas triggered ligand-independent signaling as determined by an increase in cytosolic calcium and cell migration. Notably, the calcium and motility response to ligand-induced activation was amplified in preclustered cells, suggesting a key role of receptor clustering in sensitizing the dose response to lower ligand concentrations. Ligand-independent versus ligand-induced signaling differed in the binding of arrestin-3 as a downstream effector, which was recruited to the clusters only in the presence of the ligand. This approach allows in situ receptor clustering, raising the possibility to explore different receptor activation modalities.
A single model system for integrative studies on multiple facets of antigen presentation is lacking. PAKC is a novel panel of ten cell lines knocked out for individual components of the HLA class I antigen presentation pathway. PAKC will accelerate HLA-I research in the fields of oncology, infectiology, and autoimmunity.
The lysosomal ABC transporter associated with antigen processing-like (TAPL, ABCB9) acts as an ATP-dependent polypeptide transporter with broad length selectivity. To characterize in detail its substrate specificity, a procedure for functional reconstitution of human TAPL was developed. By intensive screening of detergents, ideal solubilization conditions were evolved with respect to efficiency, long term stability, and functionality of TAPL. TAPL was isolated in a two-step procedure with high purity and, subsequently, reconstituted into proteoliposomes. The peptide transport activity of reconstituted TAPL strongly depends on the lipid composition. With the help of combinatorial peptide libraries, the key positions of the peptides were localized to the N- and C-terminal residues with respect to peptide transport. At both ends, TAPL favors positively charged, aromatic, or hydrophobic residues and disfavors negatively charged residues as well as asparagine and methionine. Besides specific interactions of both terminal residues, electrostatic interactions are important, since peptides with positive net charge are more efficiently transported than negatively charged ones.
The transporter associated with antigen processing (TAP) is an essential machine of the adaptive immune system that translocates antigenic peptides from the cytosol into the endoplasmic reticulum lumen for loading of major histocompatibility class I molecules. To examine this ABC transport complex in mechanistic detail, we have established, after extensive screening and optimization, the solubilization, purification, and reconstitution for TAP to preserve its function in each step. This allowed us to determine the substrate-binding stoichiometry of the TAP complex by fluorescence cross-correlation spectroscopy. In addition, the TAP complex shows strict coupling between peptide binding and ATP hydrolysis, revealing no basal ATPase activity in the absence of peptides. These results represent an optimal starting point for detailed mechanistic studies of the transport cycle of TAP by single molecule experiments to analyze single steps of peptide translocation and the stoichiometry between peptide transport and ATP hydrolysis.
ABC transporters are found in all organisms and almost every cellular compartment. They mediate the transport of various solutes across membranes, energized by ATP binding and hydrolysis. Dysfunctions can result in severe diseases, such as cystic fibrosis or antibiotic resistance. In type IV ABC transporters, each of the two nucleotide-binding domains is connected to a transmembrane domain by two coupling helices, which are part of cytosolic loops. Although there are many structural snapshots of different conformations, the interdomain communication is still enigmatic. Therefore, we analyzed the function of three conserved, charged residues in the intra-cytosolic loop 1 of the human homodimeric, lysosomal peptide transporter TAPL. Substitution of D278 in coupling helix 1 by alanine interrupted peptide transport by impeding ATP hydrolysis. Alanine substitution of R288 and D292, both localized next to the coupling helix 1 extending to transmembrane helix 3, reduced peptide transport but increased basal ATPase activity. Surprisingly, the ATPase activity of the R288A variant dropped in a peptide-dependent manner while ATPase activity of wildtype and D292A was unaffected. Interestingly, R288A and D292A mutants did not differentiate between ATP and GTP in respect of hydrolysis. However, in contrast to wildtype TAPL, only ATP energized peptide transport. In sum, D278 seems to be involved in bidirectional interdomain communication mediated by network of polar interactions while the two residues in the cytosolic extension of TMH3 are involved in regulation of ATP hydrolysis, most likely by stabilization of the outward facing conformation.